Compositions and methods for inferring a response to statin
OwnerTony N. Frudakisinventor
Life of this patent
Estimating the term…
Abstract
Methods for inferring a statin response of a human subject from a nucleic acid sample of the subject are provided, as are reagents such as oligonucleotide probes, primers, and primer pairs, which can be used to practice such methods. A method of inferring a statin response can be performed, for example, by identifying in a nucleic acid sample from a subject, a nucleotide occurrence of at least one statin response-related single nucleotide polymorphism (SNP) and/or at least one statin response-related haplotype in a cytochrome P450 gene and/or an HMG Co-A reductase gene.
Claims24
A method for inferring a statin response of a human subject from a nucleic acid sample of the subject, the method comprising identifying, in the nucleic acid sample, at least one haplotype allele indicative of a statin response, wherein the haplotype allele comprises
- a) nucleotides of the cytochrome p450 3A4 (CYP3A4) gene, corresponding to
- i) a CYP3A4A haplotype, which comprises
- nucleotide 808 of SEQ ID NO:8 {CYP3A4E10-5—292}, and
- nucleotide 227 of SEQ ID NO:9 {CYP3A4E12—76};
- or
- ii) a CYP3A4B haplotype, which comprises
- nucleotide 1311 of SEQ ID NO:7 {CYP3A4E7—243},
- nucleotide 808 of SEQ ID NO:8 {CYP3A4E10-5—292}, and
- nucleotide 227 of SEQ ID NO:9 {CYP3A4E12—76};
- or
- iii) a CYP3A4C haplotype, which comprises
- nucleotide 425 of SEQ ID NO:10 {CYP3A4E3-5—249},
- nucleotide 1311 of SEQ ID NO:7 {CYP3A4E7—243},
- nucleotide 808 of SEQ ID NO:8 {CYP3A4E10-5—292}, and
- nucleotide 227 of SEQ ID NO:9 {CYP3A4E12—76};
- or
- b.) nucleotides of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) gene, corresponding to:
- i) an HMGCRA haplotype, which comprises
- nucleotide 1757 of SEQ ID NO:2 {HMGCRE7E11-3—472}, and
- nucleotide 1430 of SEQ ID NO:3 {HMGCRDBSNP—45320};
- ii) an HMGCRB haplotype, which comprises
- nucleotide 519 of SEQ ID NO:11 {HMGCRE5E6-3—283},
- nucleotide 1757 of SEQ ID NO:2 {HMGCRE7E11-3—472},
- nucleotide 1430 of SEQ ID NO:3 {HMGCRDBSNP—45320}, and
- nucleotide 1421 of SEQ ID NO:12 {HMGCRE16E18—99};
- or
- iii) an HMGCRC haplotype, which comprises
- nucleotide 1757 of SEQ ID NO:2 {HMGCRE7E11-3—472},
- nucleotide 1430 of SEQ ID NO:3 {HMGCRDBSNP—45320}, and
- nucleotide 1421 of SEQ ID NO:12 {HMGCRE16E18—99},
- whereby the haplotype allele is associated with a decrease in total cholesterol or low density lipoprotein in response to administration of a statin to the subject, thereby inferring the statin response of the subject.
A method for inferring a statin response of a Caucasian subject from a nucleic acid sample of the subject, the method comprising identifying, in the nucleic acid sample, a diploid pair of alleles indicative of a statin response, wherein the diploid pair of alleles is identified for:
- a) nucleotides of the cytochrome p450 3A4 (CYP3A4) gene, corresponding to a CYP3A4C haplotype, which comprises
- nucleotide 425 of SEQ ID NO:10 {CYP3A4E3-5—249},
- nucleotide 1311 of SEQ ID NO:7 {CYP3A4E7—243},
- nucleotide 808 of SEQ ID NO:8 {CYP3A4E10-5—292}, and
- nucleotide 227 of SEQ ID NO:9 {CYP3A4E12—76};
- and
- b.) nucleotides of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) gene, corresponding to an HMGCRB haplotype, which comprises
- nucleotide 519 of SEQ ID NO:11 {HMGCRE5E6-3—283},
- nucleotide 1757 of SEQ ID NO:2 {HMGCRE7E11-3—472},
- nucleotide 1430 of SEQ ID NO:3 {HMGCRDBSNP—45320}, and
- nucleotide 1421 of SEQ ID NO:12 {HMGCRE16E18—99},
- wherein the diploid pair of CYP3A4C haplotype alleles is ATGC/ATGC, ATGC/ATAC, ATGC/AGAC, ATGC/AGAT, ATGC/ATAT, ATGC/TGAC or ATGT/AGAT, and the diploid pair of HMGCRB haplotype alleles is CGTA/CGTA, CGTA/TGTA, CGTA/CGCA, CGTA/CGTC, or CGTA/CATA, and wherein the diploid pair of haplotype alleles is associated with a decrease in total cholesterol or low density lipoprotein in response to administration of Atorvastatin or Simvastatin to the subject, thereby inferring the statin response of the subject.
A method for inferring a statin response of a human subject from a nucleic acid sample of the subject, the method comprising identifying, in the nucleic acid sample, a nucleotide occurrence of at least one statin response-related single nucleotide polymorphism (SNP) corresponding to
- nucleotide 1757 of SEQ ID NO:2 {HMGCRE7E11-3—472},
- nucleotide 1430 of SEQ ID NO:3 {HMGCRDBSNP—45320},
- nucleotide 1311 of SEQ ID NO:7 {CYP3A4E7—243},
- nucleotide 808 of SEQ ID NO:8 {CYP3A4E10-5—292},
- nucleotide 227 of SEQ ID NO:9 {CYP3A4E12—76};
- nucleotide 425 of SEQ ID NO:10 {CYP3A4E3-5—249},
- nucleotide 519 of SEQ ID NO:11 {HMGCRE5E6-3—283}, or
- nucleotide 1421 of SEQ ID NO:12 {HMGCRE16E18—99},
- whereby the nucleotide occurrence is associated with a decrease in total cholesterol or low density lipoprotein in response to administration of the statin, thereby inferring the statin response of the subject.
Dependencies are inferred from the claim text.